Exercise and Alzheimer’s: How a Hormone May Help Reduce Plaque and Tangles in the Brain
Introduction
Alzheimer’s disease is a devastating condition that affects millions of people worldwide, and finding effective treatments has been a challenge. However, recent research has shed light on a potential ally in the fight against Alzheimer’s: exercise-induced hormone irisin. This hormone, produced during physical activity, has shown promise in reducing the brain abnormalities associated with Alzheimer’s disease, including amyloid beta deposits and neurofibrillary degeneration. In this article, we will delve into the fascinating findings of a study conducted by researchers from Massachusetts General Hospital, exploring how exercise and the hormone irisin might hold the key to combating Alzheimer’s disease.
Irisin: A Hormone with Potential
Irisin is a hormone that originates in our muscles and increases in the body following exercise. Its primary role is to regulate glucose and lipid metabolism in fat tissue while also boosting energy expenditure by transforming white fat tissue into the more metabolically active brown fat. Previous studies have identified irisin in both human and mouse brains, although its levels appear diminished in individuals with Alzheimer’s disease and Alzheimer’s mouse models.
A Breakthrough in Alzheimer’s Research
The groundbreaking research conducted by a team led by scientists from Massachusetts General Hospital involved the development of 3D human cell culture models of Alzheimer’s disease. These models replicated two critical characteristics of Alzheimer’s: the formation of amyloid beta deposits (plaques) and neurofibrillary degeneration of the protein tau found in brain cells (neurons). Amyloid beta is a problematic protein known for damaging organs over time.
How Exercise Could Alleviate Alzheimer’s Symptoms
Prior to this study, exercise had already shown promise in reducing amyloid beta deposits in various mouse models of Alzheimer’s disease, but the underlying mechanisms remained elusive. Researchers sought to unravel the connection between exercise-induced irisin and its impact on amyloid beta pathology.
In their experiments, the researchers applied irisin to their 3D cell culture model of Alzheimer’s. The results were remarkable. Irisin treatment led to a significant reduction in amyloid beta pathology. This effect was attributed to increased neprilysin activity, which resulted from higher levels of neprilysin secreted by brain cells called astrocytes.
Neprilysin is an enzyme responsible for breaking down amyloid beta and is elevated in the brains of mice with Alzheimer’s who were exposed to exercise or other conditions leading to reduced amyloid beta.
Uncovering the Mechanisms Behind Irisin’s Benefits
The researchers didn’t stop there. They delved deeper into the mechanisms underlying irisin’s link to reduced amyloid beta levels. They identified a receptor that irisin binds to, prompting cells to increase neprilysin levels. Additionally, irisin’s binding to this receptor reduced the signaling of pathways involving two essential proteins: extracellular signal-regulated kinase (ERK) and signal activator of transcription 3 (STAT3). Decreasing the signaling of ERK and STAT3 is crucial for irisin to enhance neprilysin’s ability to combat amyloid beta.
Furthermore, prior studies have shown that irisin can be injected into the bloodstream of mice, where it can reach the brain. This discovery opens up new possibilities for targeted therapies.
The Potential of Alzheimer’s Research with Irisin
While the research surrounding irisin and its potential impact on Alzheimer’s disease is promising, it is still in its early stages. More human research is needed to understand the exact mechanisms involved. Future studies may compare irisin’s effects to other growth factors and explore different modes of exercise, intensities, and durations that impact irisin concentrations.
The responses of cognitively healthy adults versus those with existing cognitive impairment need further investigation. Additionally, the cognitive outcomes resulting from the expression of myokines, such as irisin, must be better understood.
The Importance of Exercise
As we eagerly await further research in this field, one thing is clear: exercise is a powerful tool for promoting brain health. For individuals with Alzheimer’s, the potential benefits of irisin offer hope for future therapies. But beyond this, the importance of exercise cannot be overstated. Physical therapist Nick Voci emphasized that exercise is medicine, and while research may pave the way for medications that mimic exercise’s effects, there is no substitute for the real thing.
In conclusion, the connection between exercise, irisin, and Alzheimer’s disease is an exciting area of research that holds promise for the future. It reinforces the idea that staying active and healthy isn’t just good for your body but also for your brain, potentially offering a new path to combat Alzheimer’s disease and improve overall cognitive health.
